Business
Wins Intelligent Formulation
Wins Intelligent Formulation.
About this update from Gunsynd Plc
[{"type":"text","content":"\n RNS Number : 3170Y Syntopix Group plc 21 December 2010 \n \n\n \n\n\n\n\nPress Release\n\n\n21 December 2010\n\n\n\n\n \nSyntopix Group plc\n(\"Syntopix\" or \"The Group\")\n \nSyntopix wins challenge to develop new microemulsions for skincare products\n \nSyntopix Group plc (AIM: SYN), the antimicrobial research company, is pleased to announce it has secured backing from Intelligent Formulation Ltd for a 30 day international research challenge into formulation design for skincare products. Intelligent Formulation, which supports businesses involved in formulation, received over 20 proposals and selected just two applicants to support, including the Syntopix bid. \n \nIntelligent Formulation will fund the month-long project that will see Syntopix work with experts from across the globe to characterise microemulsions made from environmentally friendly surfactants, especially those used to make skincare cosmetics. It is hoped the resultant data will assist scientists to formulate new cosmetic, pharmaceutical and personal care products. \n \nJust like commonly known emulsions such as paint and mayonnaise, microemulsions are a mixture of oil and water. However, unlike ordinary emulsions, microemulsions contain very small particles. This means they can be produced simply by mixing the components which results in crystal clear solutions. Commercially, microemulsions are extremely important, and can be found in foods, cosmetics and medicines as well as inks, lubricants and cleaning fluids. \n \nDr. Steve Jones, CEO of Syntopix Group plc said: \"Taking part in this challenge is very important to Syntopix and I am pleased we have been selected. Formulating microemulsions can be problematic due to its trial and error nature and is made all the more difficult by the lack of physical parameters available to inform their design. Our research project will help determine some of these essential parameters to speed up selection of ingredients. \"\n \nSteve Jones continued, \"The project will give our formulation work a huge boost and ensure we can develop products right first time, saving both time and money. We are delighted that our innovative approach to formulation has been recognised as important to the industry as a whole. \"\n \nDr. Jim Bullock, Chief Executive of Intellig...